A Phase III, randomized, double-blind, active controlled, parallel group study, comparing the efficacy, safety, and tolerability of the fixed dose combination FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled asthma

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

3

Condition

Asthma

Treatment

N/A

Clinical Study ID

TX202126
  • All Genders

Study Summary

Midwest Chest Consultants, located in St. Charles, Missouri, is currently conducting a research study with individuals with asthma.

Eligibility Criteria

Inclusion

Inclusion:

  • diagnosed with asthma
  • on maintenance inhaler (LABA/ICS)
  • at least one instance of worsening of asthma symptoms in the past year

Exclusion:

  • current smoker
  • past smoking history of 1 pack of cigarettes for 10 years (or equivalent) or more

Study Design

Study Start date:
Estimated Completion Date:

Study Description

A 24-week study consisting of 7 office visits. Breathing tests, physical exams, vital signs, ECG's, and blood tests will all be performed throughout the study.